A European Economic Area country in which an application has been submitted for authorisation of a medicine through the mutual recognition or decentralised procedure. The assessment of the medicine is performed by another country called the reference Member State.
More information can be found in 'Volume 2A: Procedures for marketing authorisation: Chapter 2: Mutual recognition'.